COVID-19

Featured

Pharma Insights
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Trending From ACCC
Positive Disruption in the COVID-19 Era: AMCCBS Virtual
Perspectives
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
Jason Shafrin, PhD, and colleagues assert that continued successful COVID-19 vaccine policies must have recognition of…
Blog
Recognizing and Testing Telehealth Models in Oncology Care First
In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative…
News
Patients With Cancer and COVID-19 Infection are at a Higher Risk for Worse Outcomes
Study results show patients with cancer are at an increased risk for COVID-19 infection and worse outcomes and this…

News

Use of Real-World EHR to Identify Disparities for COVID-19 in Patients With Cancer
Impact of COVID-19-Related Social Distancing on Cancer Outcomes
Consultation Recordings Support Shared Decision Making in Oncology During COVID-19 Pandemic
Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer

Guideline Updates

ASCO Special Report Offers Guidance on Resuming Cancer Care During COVID-19

Interviews

Pharmacists to Gain Prescriber Status? The Changing Role of Pharmacists During COVID-19

Blog

Recognizing and Testing Telehealth Models in Oncology Care First

Videos

How I Practice Now: Commercial Coverage Policy Updates for Telemedicine Services

Podcast

Episode 78: MedTwitter Reaction to COVID-19 With Anish Koka and Saurabh Jha

Conference Coverage

Clinical Pathways, Cancer Care and COVID-19